Life sciences real estate investment in Asia is shifting focus

Private equity real estate’s pivot to R&D has been a much more recent trend in the region compared with the West, as two high-profile investments show.

By

Christie Ou

30 June 2022•3 mins read

Opinion Allocation Strategy Friday Letter

Related articles

alt

PERE’s relaunch – The editors’ take

13 hours ago · 3 mins read

alt

Link’s new CEO appointment is not as surprising as one may think

9 July 2026 · 3 mins read

alt

The path to scale rarely runs smoothly

2 July 2026 · 3 mins read

alt

Two is no crowd when it comes to succession planning

25 June 2026 · 3 mins read

alt

In a risk-on market, anchor investors are opting not to go it alone

18 June 2026 · 3 mins read

alt

Core real estate stands to benefit from rising infrastructure risk

17 June 2026 · 3 mins read

alt

Investors are writing real estate checks, just not necessarily to funds

11 June 2026 · 3 mins read

motif